Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 91f481eddee36458-LAX IP: 101.37.83.79 UTC time: 2025-03-12T16:00:58+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4